IRIS Accounts Production v25.1.3.33 09867969 director 1.12.23 30.11.24 30.11.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh098679692023-11-30098679692024-11-30098679692023-12-012024-11-30098679692022-11-30098679692022-12-012023-11-30098679692023-11-3009867969ns15:EnglandWales2023-12-012024-11-3009867969ns14:PoundSterling2023-12-012024-11-3009867969ns10:Director12023-12-012024-11-3009867969ns10:PrivateLimitedCompanyLtd2023-12-012024-11-3009867969ns10:SmallEntities2023-12-012024-11-3009867969ns10:AuditExempt-NoAccountantsReport2023-12-012024-11-3009867969ns10:SmallCompaniesRegimeForDirectorsReport2023-12-012024-11-3009867969ns10:SmallCompaniesRegimeForAccounts2023-12-012024-11-3009867969ns10:FullAccounts2023-12-012024-11-3009867969ns10:CompanySecretary12023-12-012024-11-3009867969ns10:RegisteredOffice2023-12-012024-11-3009867969ns5:CurrentFinancialInstruments2024-11-3009867969ns5:CurrentFinancialInstruments2023-11-3009867969ns5:ShareCapital2024-11-3009867969ns5:ShareCapital2023-11-3009867969ns5:RetainedEarningsAccumulatedLosses2024-11-3009867969ns5:RetainedEarningsAccumulatedLosses2023-11-3009867969ns5:ComputerEquipment2023-12-012024-11-3009867969ns5:ComputerEquipment2023-11-3009867969ns5:ComputerEquipment2024-11-3009867969ns5:ComputerEquipment2023-11-3009867969ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-3009867969ns5:WithinOneYearns5:CurrentFinancialInstruments2023-11-30
REGISTERED NUMBER: 09867969 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2024

FOR

ALMPHARMA LIMITED

ALMPHARMA LIMITED (REGISTERED NUMBER: 09867969)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


ALMPHARMA LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 NOVEMBER 2024







DIRECTOR: M Atique





SECRETARY:





REGISTERED OFFICE: 40 Main Street
Cottingley
Bingley
West Yorkshire
BD16 1SR





REGISTERED NUMBER: 09867969 (England and Wales)





ACCOUNTANTS: Southbrook Accountants Limited
14 Southbrook Terrace
Bradford
West Yorkshire
BD7 1AD

ALMPHARMA LIMITED (REGISTERED NUMBER: 09867969)

BALANCE SHEET
30 NOVEMBER 2024

2024 2023
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 574 1,131

CURRENT ASSETS
Debtors 5 200,000 200,000
Cash at bank 5,066 8,121
205,066 208,121
CREDITORS
Amounts falling due within one year 6 179,890 191,233
NET CURRENT ASSETS 25,176 16,888
TOTAL ASSETS LESS CURRENT
LIABILITIES

25,750

18,019

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 25,749 18,018
SHAREHOLDERS' FUNDS 25,750 18,019

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 17 July 2025 and were signed by:





M Atique - Director


ALMPHARMA LIMITED (REGISTERED NUMBER: 09867969)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

1. STATUTORY INFORMATION

Almpharma Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - NIL ) .

ALMPHARMA LIMITED (REGISTERED NUMBER: 09867969)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2024

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 December 2023
and 30 November 2024 3,862
DEPRECIATION
At 1 December 2023 2,731
Charge for year 557
At 30 November 2024 3,288
NET BOOK VALUE
At 30 November 2024 574
At 30 November 2023 1,131

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 200,000 200,000

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 15,123 10,833
Other creditors 164,767 180,400
179,890 191,233

7. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is M Atique.